Proton Beam Therapy for Pancreatic Tumors: A Consensus Statement from the Particle Therapy Cooperative Group Gastrointestinal Subcommittee
Arpit M. Chhabra(New York Proton Center), R.C. Nichols(University of Florida), Michael D. Chuong(Baptist Hospital of Miami), J. Johnson(Mayo Clinic), Jason K. Molitoris(University of Maryland, Baltimore), Eugene J. Koay(The University of Texas MD Anderson Cancer Center), William G. Rule(Mayo Clinic in Arizona), Theodore S. Hong(Massachusetts General Hospital), Kazuki Terashima(Hyogo Ion Beam Medical Center), Christopher L. Hallemeier(Mayo Clinic in Arizona), S. Apisarnthanarax(University of Washington), Charles B. Simone(New York Proton Center), Shahed N. Badiyan(University of Maryland, Baltimore), Adeel Kaiser(Miami Heart Research Institute), Richard A. Amos(University College London), Eric S. Diffenderfer(University of Pennsylvania), Haibo Lin(New York Proton Center), Pavel Vítek(Czech Academy of Sciences, Global Change Research Institute), Hideyuki Sakurai(University of Tsukuba), John A. Wolfgang(Massachusetts General Hospital), Hsiao-Ming Lu(Anhui Medical University), Huan Giap(University of Miami), Andrew Wroe(Miami Heart Research Institute), L Perles(The University of Texas MD Anderson Cancer Center)
International Journal of Radiation Oncology*Biology*Physics
January 5, 2025
Cited by 8
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914
Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
|JAMA Oncology|2022|557